<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02846922</url>
  </required_header>
  <id_info>
    <org_study_id>20160020</org_study_id>
    <nct_id>NCT02846922</nct_id>
  </id_info>
  <brief_title>Catheter Ablation and Rate Control of Atrial Fibrillation in Patients With Heart Failure</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nanjing Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nanjing Medical University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To evaluate the efficacy of catheter ablation and rate control in heart failure patients with
      atrial fibrillation.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      All patients received either catheter ablation for rhythm control or rate control before
      enrollment, and the investigators do not assign specific interventions to the subjects during
      the study. So this study might be considered to be observational.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2016</start_date>
  <primary_completion_date type="Actual">November 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Major adverse cardiac events</measure>
    <time_frame>up to 3 years</time_frame>
    <description>composite of all-cause mortality, stroke and unplanned hospitalization due to cardiovascular reasons</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>all-cause mortality</measure>
    <time_frame>up to 3 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>stroke</measure>
    <time_frame>up to 3 years</time_frame>
    <description>stroke must be certified by CT scan</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>unplanned hospitalization due to cardiovascular reasons</measure>
    <time_frame>up to 3 years</time_frame>
    <description>Unplanned hospitalization will be present only if the patient is hospitalized unexpectedly because of persisting or increasing complaints of heart failure and ventricular arrhythmias</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">394</enrollment>
  <condition>Catheter Ablation</condition>
  <condition>Rate Control</condition>
  <condition>Heart Failure</condition>
  <condition>Atrial Fibrillation</condition>
  <arm_group>
    <arm_group_label>catheter ablation group</arm_group_label>
    <description>atrial fibrillation patients with heart failure who received catheter ablation for rhythm control</description>
  </arm_group>
  <arm_group>
    <arm_group_label>rate control group</arm_group_label>
    <description>atrial fibrillation patients with heart failure who received pharmacological approaches for rate control</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients coexisted with heart failure and atrial fibrillation
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age&gt;18 years

          -  documented atrial fibrillation

          -  New York Heart Association Ⅱ-Ⅳ or left ventricular ejection fraction &lt;50%

        Exclusion Criteria:

          -  heart failure that had a suspected reversible cause

          -  previous ablation

          -  any contraindication to catheter ablation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jin Geng, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Bingjian Wang, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Huai'an First People's Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Drum Tower Hospital</name>
      <address>
        <city>Nanjing</city>
        <state>Jiangsu</state>
        <zip>210008</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>January 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 25, 2016</study_first_submitted>
  <study_first_submitted_qc>July 25, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 27, 2016</study_first_posted>
  <last_update_submitted>January 4, 2017</last_update_submitted>
  <last_update_submitted_qc>January 4, 2017</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 6, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Nanjing Medical University</investigator_affiliation>
    <investigator_full_name>Jin Geng</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
    <mesh_term>Atrial Fibrillation</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

